Smith & Nephew walks back layoff talk; Ampio launches Dx subsidiary;

 @FierceMedDev: Israeli team advances genetic device to perform DNA diagnosis. Report | Follow @FierceMedDev

 @MarkHFierce: Indiana offers a way to work around the device tax, rather than focusing on repealing it. More | Follow @MarkHFierce

 @DamianFierce: Pfizer's ongoing R&D slash and burn could be good news for CROs. Story | Follow @DamianFierce

> A former Lazard banker will be starting a debt fund in Europe to invest in medical technology, diagnostics and life sciences companies. Story

> Smith & Nephew ($SNN) CEO Olivier Bohuon now denies an earlier company statement blaming planned layoffs on the U.S. medical device industry tax. Item

> Ampio Pharmaceuticals ($AMPE) has launched a subsidiary, Luoxis Diagnostics, an in-vitro Dx company that will market the Oxidation Reduction Potential platform. More

> Life Technologies ($LIFE) picked up FDA clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits, designed to determine compatibility between tissue donors. News

> Australia diagnostic company Cellmid will license its anti-midkine diagnostic antibodies to Japan's Fujikura Kasei Co., a major supplier of latex particles used in medical diagnostics. Release

> Planmed Oy won FDA clearance for Verity, a device designed to detect subtle extremity fractures. Item

> Vexim is launching a U.K. subsidiary to expand market reach for its minimally invasive treatment of vertebral fractures. Release

Biotech News

 @FierceBiotech: Sanofi move to acquire more shares of Regeneron triggers market buzz. Report | Follow @FierceBiotech

@JohnCFierce: Tresiba news underscores how high the FDA sets the bar on diabetes. Hard for biotechs to play in a field like this. News | Follow @JohnCFierce

@RyanMFierce: 'Mercenary' coders crowd-sourced for immunology research software. Report | Follow @RyanMFierce

> Bayer hands off FDA app as pulmonary hypertension drug race heats up. Story

> Spurning panel endorsement, FDA rejects Novo's long-acting insulin Tresiba. Article

Pharma News

@FiercePharma: Corks pop at Sanofi as FDA nixes Novo's Lantus challenger. Article | Follow @FiercePharma

@EricPFierce: New Celgene drug for multiple myeloma expected to help fuel expansion of market to $7.2 billion. News | Follow @EricPFierce

@AlisonBFierce: A genetically modified smallpox vaccine shrunk tumors in liver cancer patients and extended survival more than a year. More | Follow @AlisonBFierce

> FDA hearing on opioids reflects evolving view on painkiller use. Report

> Will NIH data win Avastin a new use in cervical cancer? Story

CRO News

> GSK ups the ante for trial transparency. Story

> Struggling Cardiome recruits Quintiles to handle heart drug. More

> Struggling Cardiome recruits Quintiles to handle heart drug. News

> QPS snags Florida trial site amid buying spree. Report

> Pfizer's Singapore slash and burn could be good news for CROs. Article

Biotech IT News

> Trials software outfit BioClinica reports annual results (for the last time?) Item

> Sanofi backs mobile service for cancer patients on chemo. News

> 'Mercenary' coders crowd-sourced for immunology research software. Report

> Biotech, pharma warming up to Facebook. Article

> Eli Lilly's virtual unit taps Oracle software for clinical trials. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.